|
|
| (6 intermediate revisions by 2 users not shown) |
| Line 1: |
Line 1: |
| == Operations == | | == Summary == |
|
| |
|
| === How did the idea of the company come about? ===
| | Summary section of the report needs updating. |
| Pfizer is a pharmaceutical company that was founded in 1849 by Charles Pfizer and Charles Erhart. The idea for the company came about when Charles Pfizer, a chemist, and his cousin, Charles Erhart, a confectioner, recognized the potential of manufacturing and marketing chemicals for medical purposes. They started by producing and selling santonin, an antiparasitic medication, and quickly expanded their operations to include other pharmaceutical products.
| |
|
| |
|
| === Mission ===
| | [[User:Manos|Manos]] ([[User talk:Manos|talk]]) 08:32, 17 July 2023 (BST) |
| The mission of Pfizer is to discover, develop, and provide innovative medicines and vaccines that improve the health and well-being of people around the world. Pfizer aims to be a leader in the biopharmaceutical industry by advancing scientific knowledge, investing in research and development, and delivering high-quality healthcare solutions.
| |
|
| |
|
| Pfizer's mission encompasses several key elements:
| | == References == |
|
| |
|
| 1. Discovery and Development: Pfizer is committed to scientific discovery and the development of new medicines and vaccines. They invest in research to uncover breakthroughs, advance scientific knowledge, and explore potential treatment options for various diseases and conditions.
| | Need to add references throughout the report. |
|
| |
|
| 2. Innovation: Pfizer strives for innovation in its approach to healthcare. They seek to develop new and improved therapies, technologies, and solutions that address unmet medical needs and contribute to better health outcomes for patients.
| | [[User:Manos|Manos]] ([[User talk:Manos|talk]]) 08:32, 17 July 2023 (BST) |
|
| |
|
| 3. Global Impact: Pfizer's mission extends to a global scale. They aim to make a positive impact on the health and well-being of people worldwide. This involves providing access to their medicines and vaccines, particularly in underserved populations, and collaborating with healthcare partners and organizations to address healthcare challenges globally.
| | == Financial forecasts projects == |
|
| |
|
| 4. Patient-Centered Approach: Pfizer is dedicated to putting patients at the center of everything they do. They aim to understand patient needs, provide effective treatments, and improve patient outcomes and quality of life.
| | Add the assumptions behind the projections, or if the projections are from a third-party, such as Goldman Sachs, add the source. On reflection, I think the financial forecast assumptions are found in the valuation section of the report? If so, make that clearer in the financial forecasts section of the report. |
|
| |
|
| By embracing these principles, Pfizer seeks to fulfill its mission of discovering, developing, and delivering innovative medicines and vaccines that contribute to the advancement of healthcare and the improvement of people's lives.
| | [[User:Manos|Manos]] ([[User talk:Manos|talk]]) 08:32, 17 July 2023 (BST) |
| | |
| === Products ===
| |
| | |
| ==== Summary ====
| |
| Pfizer offers a wide range of products and services in the healthcare sector. Their main offerings include prescription medications, vaccines, and consumer healthcare products. They have developed and marketed numerous successful drugs across various therapeutic areas, including cardiovascular diseases, oncology, immunology, neurology, and rare diseases. Some well-known Pfizer products include Viagra, Lipitor, Lyrica, Prevnar, and Xeljanz. They also have a significant presence in the field of vaccines, with notable contributions like the COVID-19 vaccine developed in collaboration with BioNTech. Additionally, Pfizer offers over-the-counter healthcare products for consumers, such as pain relievers, vitamins, and personal care items.
| |
| | |
| ==== Offering Categories ====
| |
| The main offerings of Pfizer can be categorized into three primary areas: prescription medications, vaccines, and consumer healthcare products. Here's an overview of each category:
| |
| | |
| ===== 1. Prescription Medications =====
| |
| Pfizer develops and markets a broad range of prescription drugs across various therapeutic areas. Some notable offerings include:
| |
| | |
| - Lipitor (atorvastatin): A medication used to lower cholesterol levels.
| |
| | |
| - Viagra (sildenafil): A medication for the treatment of erectile dysfunction.
| |
| | |
| - Lyrica (pregabalin): A drug prescribed for neuropathic pain, fibromyalgia, and certain types of seizures.
| |
| | |
| - Celebrex (celecoxib): A nonsteroidal anti-inflammatory drug (NSAID) used for pain relief and inflammation reduction.
| |
| | |
| - Xeljanz (tofacitinib): A medication for the treatment of rheumatoid arthritis and other autoimmune conditions.
| |
| | |
| ===== 2. Vaccines =====
| |
| Pfizer has a significant presence in the development and production of vaccines. Notable vaccine offerings include:
| |
| | |
| - COVID-19 Vaccine (developed in collaboration with BioNTech): A highly effective vaccine to prevent COVID-19.
| |
| | |
| - Prevnar 13 (pneumococcal 13-valent conjugate vaccine): A vaccine to protect against pneumococcal diseases, including pneumonia.
| |
| | |
| ===== 3. Consumer Healthcare Products =====
| |
| Pfizer also offers a range of over-the-counter healthcare products for consumers. These include:
| |
| | |
| - Advil (ibuprofen): An over-the-counter pain reliever and fever reducer.
| |
| | |
| - Centrum: A line of multivitamin and mineral supplements.
| |
| | |
| - Caltrate: A brand of calcium supplements for bone health.
| |
| | |
| - ChapStick: A popular lip balm product.
| |
| | |
| It's important to note that Pfizer's product portfolio may vary based on geographic regions and evolving market demands.
| |
|
| |
|
| == Research report example == | | == Research report example == |
| Line 65: |
Line 22: |
| == Key source(s) of information == | | == Key source(s) of information == |
| A prime source of insightful information about this company is the company itself. Specifically, the annual report provides comprehensive details about its financial status and business progress. You can access this valuable resource at the following link: [https://investors.pfizer.com/Investors/Overview/default.aspx Pfizer's Annual Report]. Another key source is that of the company's competitors. | | A prime source of insightful information about this company is the company itself. Specifically, the annual report provides comprehensive details about its financial status and business progress. You can access this valuable resource at the following link: [https://investors.pfizer.com/Investors/Overview/default.aspx Pfizer's Annual Report]. Another key source is that of the company's competitors. |
|
| |
| == Risks ==
| |
|
| |
| Following risks or uncertainties include the following:
| |
|
| |
| # '''Risks related to business, industry and operations'''
| |
|
| |
| {| class="wikitable"
| |
| |+
| |
| !
| |
| !Risk
| |
| |-
| |
| |
| |
| |The outcome to meet anticipated pre-clinical and clinical endpoints, and to be able to meet regulatory approval with the possibility of potential unfavourable pre-clinical or clinical data.
| |
| |-
| |
| |
| |
| |Able to address comments and concerns from regulatory authorities and to be able to obtain approval for new products.
| |
| |-
| |
| |
| |
| |Claims and concerns in regards to the safety of efficiacy of products and product candidates.
| |
| |-
| |
| |
| |
| |Competition from new product entrants, including but not limited to; generic products, private label products and biosimilars.
| |
| |-
| |
| |
| |
| |Impact of public health outbreaks impacting on business, operations and financial conditions.
| |
| |-
| |
| |
| |
| |Impact of increased presence of counterfeit medicines or vaccines in the pharmaceutical supply chain.
| |
| |-
| |
| |
| |
| |Impact of increased presence of counterfeit medicines or vaccines in the pharmaceutical supply chain.
| |
| |}
| |
| '''2. Risks related to Government Regulation and Legal Proceedings'''
| |
| {| class="wikitable"
| |
| |+
| |
| !
| |
| !Risks
| |
| |-
| |
| |
| |
| |The impact of any U.S. healthcare reform involving cost controls affecting publicly funded health programs that may be implemented.
| |
| |-
| |
| |
| |
| |Governmental regulations affecting operations.
| |
| |}
| |
| '''3. Risks involving Intellectual Property, Technology and Security'''
| |
| {| class="wikitable"
| |
| |+
| |
| !
| |
| !Risks
| |
| |-
| |
| |
| |
| |Business disruption, theft of information that result in an integrity comprimise resulting from a cyber-attack.
| |
| |-
| |
| |
| |
| |Risks to products, patents and other IP including, claims of invalidity, patent infringemen and pressure or regulatory action by the government or large stakeholders.
| |
| |}
| |
Summary section of the report needs updating.
Manos (talk) 08:32, 17 July 2023 (BST)Reply[reply]
Need to add references throughout the report.
Manos (talk) 08:32, 17 July 2023 (BST)Reply[reply]
Add the assumptions behind the projections, or if the projections are from a third-party, such as Goldman Sachs, add the source. On reflection, I think the financial forecast assumptions are found in the valuation section of the report? If so, make that clearer in the financial forecasts section of the report.
Manos (talk) 08:32, 17 July 2023 (BST)Reply[reply]
Take a look at this commended research report on Tesla, Inc. from the Stockhub platform: https://stockhub.co/research/Tesla,_Inc. While it has garnered positive feedback, remember that it's simply a reference - there's no obligation to adhere strictly to its style or content.
A prime source of insightful information about this company is the company itself. Specifically, the annual report provides comprehensive details about its financial status and business progress. You can access this valuable resource at the following link: Pfizer's Annual Report. Another key source is that of the company's competitors.
